Karyotype pecularities of human colorectal adenocarcinomas

Human Genetics

Volumn 86, Issue 5, 1991, Pages 491-496

  Konstantinova, L N ^a   Fleischman, E W ^a   Knisch, V I ^b   Perevozchikov, A G ^b   Kopnin, B P ^a  

^a Research Institute of Carcinogenesis   (Russian Federation)

^b AMS of the USSR ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; COLORECTAL TUMOR; FEMALE; GENETICS; HUMAN; KARYOTYPING; MALE; CHROMOSOME 17P; CHROMOSOME LOSS; CLINICAL ARTICLE; COLON CARCINOMA; COLORECTAL CARCINOMA; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; COLORECTAL NEOPLASMS; FEMALE; HUMAN; KARYOTYPING; MALE; MIDDLE AGE;

EID: 0025922875     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/BF00194640     Document Type: Article

References (40)

1. Chromosome 17p loss in carcinoma of the cervix uteri
2. Chromosome 17p deletions and p53 gene mutations in colorectal carcinomas
3. Mapping the gene for hereditary cutaneous malignant melanoma — dysplastic nevus to chromosome 1p
4. Localization of the gene for familial adenomatous polyposis on chromosome 5
5. Human chromosome analysis in 24 cases of primary carcinoma of the large intestine: contribution of the G-banding technique
6. Role of chromosome translocations in human neoplasia
7. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression
8. Non correlation of the expression of the c-myc oncogene in colorectal carcinomas with recurrence of disease or patient survival
9. Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation
10. Clonal analysis of human colorectal tumors
11. Cytogenetic study of rectosigmoidal adenocarcinomas
12. The variable hematologic expression of the BCR/ABL genomic mutation and its possible determinants
13. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification
14. The c- ets-1 proto-oncogene is rearranged in some cases of acute lymphoblastic leukemia
15. Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22
16. Oncogenes and tumor supressor genes
17. Multiple phenotypic consequences of the Ig/Myc translocation in B-cell derived tumors
18. VNTR (variable number of tandem repeats) markers show loss of chromosome 17p sequences in human colorectal carcinomas
19. Tumor supressor genes
20. Chromosome analysis of primary large bowel tumors: a new method for improving the yield of analyzable metaphases
21. Loss of the alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas
22. Consistent deficiences of chromosome 18 and of the short arm of chromosome 17 in eleven cases of human large bowel cancer: a possible recessive determinism
23. Recurrent deletions of chromosomes 11q and 3p in anal canal carcinoma
24. Characteristic chromosomal pattern in colorectal carcinoma. 2nd International Workshop on Chromosomes in Solid Tumors, Tucson, Arizona, 1987
25. Existence of two distinct processes of chromosomal evolution in near-diploid colorectal tumors
26. Double minutes in human large bowel cancer
27. Chromosomal banding patterns in human large bowel cancer
28. Chromosomes in human large bowel tumors. A study of chromosome 1
29. Marker chromosomes in direct preparations of human large bowel tumors
30. Amplification and rearrangement of Hu- ets-1 in leukemia and lymphoma with involvement of 11q23
31. Chromosome 5 allele loss in human colorectal carcinomas
32. Involvement of bands 9q21–22 in five cases of acute nonlymphocytic leukemia
33. Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues
34. Karyotype and molecular analysis of colon cancer. 2nd International Workshop on Chromosomes in Solid Tumors, Tucson, Arizona, 1987
35. Genetic alterations during colorectal tumor development
36. Allelotype of colorectal carcinomas
37. Alterations of myc, myb, and ras-HA proto-on-cogenes in cancers are frequent and show clinical correlation